Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Acta Psychiatr Scand ; 120(4): 329-31, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19573048

ABSTRACT

OBJECTIVE: We report a patient who experienced delusional symptoms during gradual discontinuation of low-dose venlafaxine and required antipsychotic treatment. METHOD: Case report. RESULTS: A 31-year-old woman with major depression had been treated abroad with venlafaxine before returning to Japan. Since venlafaxine is unavailable here, we supplemented her regular venlafaxine dosage of 37.5 mg/day with clomipramine 20 mg/day. After 5 weeks we reduced venlafaxine to 18.75 mg/day and uptitrated clomipramine to 40 mg/day. Four days later she developed delusions of reference, palpitations and nausea. Clomipramine was increased to 60 mg/day, and her symptoms subsided. Eight weeks later her supply of venlafaxine ran out, and within 4 days her condition deteriorated into more severe symptoms that required 4 months' antipsychotic treatment. CONCLUSION: We speculate that her symptoms were discontinuation syndrome, including psychotic symptoms and physical symptoms, caused by (i) venlafaxine-clomipramine interaction and/or (ii) the serotonin reuptake inhibitor-like effects of low-dose venlafaxine.


Subject(s)
Cyclohexanols/adverse effects , Delusions/etiology , Depressive Disorder, Major/drug therapy , Selective Serotonin Reuptake Inhibitors/adverse effects , Substance Withdrawal Syndrome/etiology , Adult , Clomipramine/therapeutic use , Cyclohexanols/administration & dosage , Delusions/drug therapy , Delusions/psychology , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Interactions , Female , Humans , Selective Serotonin Reuptake Inhibitors/administration & dosage , Severity of Illness Index , Venlafaxine Hydrochloride
SELECTION OF CITATIONS
SEARCH DETAIL
...